FDA, HIV Treatment and Prevention Agents and Hospitals

Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention

Pharmaceutical Technology

JULY 2, 2025

Gilead’s recently approved drug for HIV prevention, Yeztugo (lenacapavir), has the potential to transform the pre-exposure prophylaxis (PrEP) sector in the US, according to market analysts. Go deeper with GlobalData Reports LOA and PTSR Model - BRII-732 in Human Immunodeficiency Virus (HIV).

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Packaging FDA Communication

Gilead hit with FDA clinical hold for batch of HIV trials

Pharmaceutical Technology

JUNE 11, 2025

The US Food and Drug Administration (FDA) has placed a clinical hold on several of Gilead’s trials evaluating two HIV treatment candidates, though the rest of the drugmaker’s diverse pipeline remains unaffected. Gilead is considered the leading big pharma in HIV treatments. Shares in Nasdaq-listed Gilead opened 0.3%

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents FDA Communication Hospitals

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Pharmacy Times

JUNE 10, 2025

Meloxicam injection (Xifyrm; Azurity Pharmaceuticals, Inc) received FDA approval for use in adults for the management of moderate-to-severe pain, either alone or in combination with non-steroidal anti-inflammatory drug (NSAID) analgesics.

FDA

FDA HIV Treatment and Prevention Agents Compounding Pharmacies Hospitals

ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide

Pharmacy Times

JUNE 23, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Compounding Pharmacies Immunization FDA

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

Pharmacy Times

JUNE 16, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Chemotherapy Compounding Pharmacies Immunization

Protecting Older Adults from Severe RSV: Key Challenges and the Importance of Prevention

Pharmacy Times

JULY 3, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Compounding Pharmacies Vaccines Hospitals

The Checkup by Singlecare - Untitled Article

The Checkup by Singlecare

SEPTEMBER 26, 2023

Paxlovid can be a useful drug that can decrease the risk of hospitalization or death in high-risk individuals with COVID-19. Key takeaways Paxlovid is an FDA -approved drug for treating mild to moderate COVID-19 in high-risk individuals. Several substances, including herbal products, may interact with Paxlovid.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Dosage Adverse Reactions Immunization

Pharmacists Have a Crucial Role Helping Patients With ATTR-CM Navigate Treatment With Tafamidis

Pharmacy Times

JULY 1, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Specialty Pharmacies Compounding Pharmacies Hospitals

Oral COVID Agents

Pharmacy Friday Pearls

MARCH 4, 2022

18 years Administration Oral Oral Oral PK/PD MOA: Nirmatrelvir – inhibitor of the SARS-CoV-2 main protease Prevents viral replicationRitonavir is a CYP3A inhibitor included to increase nirmatrelvir plasma levelsRitonavir alone has NO activity against SARS-CoV-2 Time to peak: Nirmatrelvir: 3 hrs & Ritonavir: 3.98 Introduction.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Hospitals Packaging Immunization

Year In Review: Top Infectious Diseases Articles From 2024

IDStewardship

DECEMBER 11, 2024

Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections | NEJM BALANCE RCT : Among hospitalized patients with bloodstream infection, antibiotic treatment for 7 days was non-inferior to treatment for 14 days. RANDOMIZED CONTROLLED TRIALS 1. aureus bloodstream infection.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Labelling Hospitals FDA

Ivermectin: A therapeutic approach to reduce high-risk cases of COVID

Druggist

SEPTEMBER 2, 2021

Additionally, this drug is also known as anti-parasite successful against all viruses like HIV, Dengue, Influenza , and Zika virus. And stated its judicial use in preventing corona infection. To manage such a future crisis, healthcare experts might consider using Ivermectin tablets for its treatment and prevention.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Adverse Reactions Hospitals FDA

How Balancing Iron Levels Can Help Your Thyroid

The Thyroid Pharmacist

JULY 20, 2023

And as we’ve seen, even with supplementation, you need to address your root causes to prevent iron supply and demand challenges. Viruses that have been associated with anemia include Epstein-Barr Virus , hepatitis A and C, human herpes virus 6 (HHV-6), cytomegalovirus, parvovirus B19, and HIV. [45] However, when they added 1.5

Health and Personal Care Stores

Health and Personal Care Stores HIV Treatment and Prevention Agents Insurance Immunization

Pharmacy Technician Pulse

Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention

Gilead hit with FDA clinical hold for batch of HIV trials

Trending Sources

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

Protecting Older Adults from Severe RSV: Key Challenges and the Importance of Prevention

The Checkup by Singlecare - Untitled Article

Pharmacists Have a Crucial Role Helping Patients With ATTR-CM Navigate Treatment With Tafamidis

Oral COVID Agents

Year In Review: Top Infectious Diseases Articles From 2024

Ivermectin: A therapeutic approach to reduce high-risk cases of COVID

How Balancing Iron Levels Can Help Your Thyroid

Stay Connected